Safety and Effectiveness of a New Protease Inhibitor, BMS-232632, in HIV-Positive Patients Who Have Received Previous Treatment

This study has been completed.
Information provided by:
Bristol-Myers Squibb Identifier:
First received: February 10, 2000
Last updated: April 28, 2011
Last verified: April 2011
No Study Results Posted on for this Study
  Study Status: This study has been completed.
  Study Completion Date: January 2002
  Primary Completion Date: January 2002 (Final data collection date for primary outcome measure)